Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence
{{output}}
Background: Temozolomide (TMZ) is the standard chemotherapy for gliomas due to good tolerability. Clinical studies suggest a combination of procarbazine, lomustine (CCNU) and vincristine (PCV) provides superior survival and progr... ...
